SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-12-472543
Filing Date
2012-11-15
Accepted
2012-11-15 16:02:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D d440300dsc13d.htm SC 13D 44980
  Complete submission text file 0001193125-12-472543.txt   46781
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Subject) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-51051 | Film No.: 121208728
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958
Business Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958 33 6 33554531
LFB Biotechnologies S.A.S.U. (Filed by) CIK: 0001377942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13D